Frew, P. M., Paine, M. B., Rouphael, N., Schamel, J., Chung, Y., Mulligan, M. J., & Prausnitz, M. R. (2020). Acceptability of an inactivated influenza vaccine delivered by microneedle patch: Results from a phase I clinical trial of safety, reactogenicity, and immunogenicity. Vaccine, 38(45), 7175-7181. https://doi.org/10.1016/j.vaccine.2020.07.064
Chicago Style (17th ed.) CitationFrew, Paula M., Michele Bennett Paine, Nadine Rouphael, Jay Schamel, Yunmi Chung, Mark J. Mulligan, and Mark R. Prausnitz. "Acceptability of an Inactivated Influenza Vaccine Delivered by Microneedle Patch: Results from a Phase I Clinical Trial of Safety, Reactogenicity, and Immunogenicity." Vaccine 38, no. 45 (2020): 7175-7181. https://doi.org/10.1016/j.vaccine.2020.07.064.
MLA (9th ed.) CitationFrew, Paula M., et al. "Acceptability of an Inactivated Influenza Vaccine Delivered by Microneedle Patch: Results from a Phase I Clinical Trial of Safety, Reactogenicity, and Immunogenicity." Vaccine, vol. 38, no. 45, 2020, pp. 7175-7181, https://doi.org/10.1016/j.vaccine.2020.07.064.